相关实验视频

Updated: Jun 5, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

用于识别帕金森病器件辅助治疗候选人的人工智能:DELIST-PD研究

Eric Freire-Álvarez¹, Inés Legarda Ramírez², Rocio García-Ramos³

¹Hospital General Universitario de Elche, Alicante, Spain.

Computers in biology and medicine

|December 5, 2024

概括

人工智能 (AI) 有效地识别了帕金森病 (PD) 患者的设备辅助疗法 (DAT). 一个CatBoost模型准确地预测了适合性,改善了高级PD的治疗选择.

科学领域:

神经学神经学
人工智能的人工智能
机器学习机器学习

背景情况:

传统的帕金森病 (PD) 治疗方法随着时间的推移而失效.
先进的PD需要优化治疗选择以获得更好的结果.
设备辅助疗法 (DAT) 为PD提供了先进的治疗选择.

研究的目的:

通过使用人工智能 (AI) 增强用于高级帕金森病 (PD) 的设备辅助疗法 (DAT) 候选人的识别.
为了解决在晚期PD阶段改善治疗选择的需要.

主要方法:

这是一项针对西班牙1086名PD患者进行的国家,多中心的观察性研究.
机器学习 (ML) 算法的评估:CatBoost,支持矢量机 (SVM) 和后勤回归 (LR).
根据临床和人口统计数据识别DAT候选者.

主要成果:

在识别DAT候选物中,CatBoost算法获得了卓越的性能 (AUC0.95,灵敏度0.91,特异性0.88).
对DAT适合性的关键预测因素包括每日"关闭"时间,利沃多巴剂量和PD持续时间.
确定了一个决策值:每天超过4个乐伏多巴片和/或每天"关闭"时间≥1.8小时.

结论:

开发了一个高度有区别的CatBoost模型,用于识别适合DAT的PD患者.
这种人工智能方法可以改善高级PD的及时和准确的治疗选择.
人工智能工具帮助神经病学家优化移动障碍单位的转诊.

关键词:

决策支持技术决策支持技术深度学习是一种深度学习.设备辅助疗法是一种辅助疗法.帕金森病的疾病.

更多相关视频

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...